Screening for alpha1-Pi deficiency in patients with lung diseases
- PMID: 12212962
- DOI: 10.1183/09031936.02.02012001
Screening for alpha1-Pi deficiency in patients with lung diseases
Abstract
In patients with pulmonary emphysema, studies have reported 2-3% of individuals with severe alpha1-Pi deficiency. The aims of this study were to evaluate the accuracy of a new method for quantifying alpha1-Pi through phenotyping from dried blood spots (DBS) and to test the hypothesis that the screening of a population at risk increases the detection rate for severe alpha1-Pi deficiency. The accuracy of phenotyping results from DBS was compared to conventional methods in a total of 555 individuals. In a prospective study 1,060 patients with chronic lung disease were screened for alpha1-Pi deficiency using DBS. The validation of the phenotyping method from DBS showed an accuracy of 100%. Out of 1,060 tested patients, none had a severe PiZ deficiency and only 3 had PiSZ, whilst 36 (3.34%) individuals were identified as heterozygous for PiMS and 39 (3.68%) for PiMZ. No patients with severe alpha1-Pi deficiency could be detected in this population and the frequency of PiMS or PiMZ detected was similar to that of the normal population. Thus, the screening of an unselected population of chronic obstructive pulmonary disease and asthma patients may not detect a large number of individuals with severe alpha1-Pi deficiency.
Similar articles
-
Simple method for alpha1-antitrypsin deficiency screening by use of dried blood spot specimens.Eur Respir J. 2000 Jun;15(6):1111-5. doi: 10.1034/j.1399-3003.2000.01521.x. Eur Respir J. 2000. PMID: 10885432
-
Spanish Registry of Patients With Alpha-1 Antitrypsin Deficiency; Comparison of the Characteristics of PISZ and PIZZ Individuals.COPD. 2015 May;12 Suppl 1:27-31. doi: 10.3109/15412555.2015.1021912. COPD. 2015. PMID: 25938288
-
[Screening for alpha1-antitrypsin deficiency using dried blood spot: Assessment of the first 20 months].Rev Mal Respir. 2020 Oct;37(8):633-643. doi: 10.1016/j.rmr.2020.08.001. Epub 2020 Aug 25. Rev Mal Respir. 2020. PMID: 32859429 French.
-
Heterozygous alpha 1-antitrypsin deficiency (PiSZ) in an adolescent with asthma.South Med J. 1996 Oct;89(10):1011-3. doi: 10.1097/00007611-199610000-00018. South Med J. 1996. PMID: 8865800 Review.
-
Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys.Chest. 2002 Nov;122(5):1818-29. doi: 10.1378/chest.122.5.1818. Chest. 2002. PMID: 12426287 Review.
Cited by
-
Targeted screening programmes in COPD: how to identify individuals with α1-antitrypsin deficiency.Eur Respir Rev. 2015 Mar;24(135):40-5. doi: 10.1183/09059180.00010614. Eur Respir Rev. 2015. PMID: 25726553 Free PMC article. Review.
-
Prevalence of α1-antitrypsin PiZZ genotypes in patients with COPD in Europe: a systematic review.Eur Respir Rev. 2020 Jul 21;29(157):200014. doi: 10.1183/16000617.0014-2020. Print 2020 Sep 30. Eur Respir Rev. 2020. PMID: 32699024 Free PMC article.
-
Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency.Respir Res. 2018 Aug 13;19(1):151. doi: 10.1186/s12931-018-0826-8. Respir Res. 2018. PMID: 30103740 Free PMC article. Clinical Trial.
-
Alpha-1 antitrypsin deficiency in Iranian patients with chronic obstructive pulmonary disease.Iran Red Crescent Med J. 2013 Nov;15(11):e7508. doi: 10.5812/ircmj.7508. Epub 2013 Nov 5. Iran Red Crescent Med J. 2013. PMID: 24719685 Free PMC article.
-
Alpha-1-antitrypsin deficiency: increasing awareness and improving diagnosis.Ther Adv Respir Dis. 2016 Feb;10(1):72-84. doi: 10.1177/1753465815602162. Epub 2015 Sep 4. Ther Adv Respir Dis. 2016. PMID: 26341117 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous